Synced daily from ClinicalTrials.gov via AACT. Last sync: .
12 TAK-279 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 7 indications (including Healthy Volunteers & Plaque Psoriasis) and 4,780 total planned enrollment. 4 Phase 3 TAK-279 trials and 2 Phase 2 are listed. 1 TAK-279 clinical trial is actively recruiting at 23 U.S. sites across 14 states. Most recent activity: NCT06550076 (Aug 2029).
Where to Participate: All TAK-279 Trial Sites in the U.S. (23 sites across 14 states)
Every actively recruiting TAK-279trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis
A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
12 TAK-279 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 8 are marked completed.
Are TAK-279 clinical trials recruiting in 2026?
Yes — 1 TAK-279 trial is actively recruiting in 2026, with 23 U.S. sites across 14 states. See the recruiting trials and the per-state site list further down this page.
What conditions is TAK-279 being studied for?
TAK-279 is being studied for Healthy Volunteers, Plaque Psoriasis, Generalized Pustular Psoriasis, Hepatic Impairment, Renal Impairment and 3 more. The trials are grouped by indication on this page.
What phase is TAK-279 in?
TAK-279 clinical trials span 4 Phase 3, 2 Phase 2, 6 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors TAK-279 clinical trials?
The lead sponsor across the most TAK-279 trials is Takeda. Each trial row links to the full study detail page including sponsor information.
Sources and methodology
Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming TAK-279as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.